P1139: COMPARISON OF 6XR-CHOP21 VERSUS 6XR-CHOP+2R FOR ADVANCED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: A PROPENSITY SCORE WEIGHTED POPULATION-BASED ANALYSIS
Carolien Maas,
David van Klaveren,
Mujde Durmaz,
Otto Visser,
Djamila Issa,
Eduardus F.M. Posthuma,
Josée Zijlstra,
Martine Chamuleau,
Pieternella Lugtenburg,
Marie José Kersten,
Avinash Dinmohamed
Affiliations
Carolien Maas
1 Erasmus University Medical Centre, Department of Public Health, Rotterdam, The Netherlands
David van Klaveren
1 Erasmus University Medical Centre, Department of Public Health, Rotterdam, The Netherlands
Mujde Durmaz
2 Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research and Development, Utrecht, The Netherlands
Otto Visser
3 Netherlands Comprehensive Cancer Organisation (IKNL), Department of Registration, Utrecht, The Netherlands
Djamila Issa
4 Jeroen Bosch Hospital, Department of Internal Medicine, Den Bosch, The Netherlands
Eduardus F.M. Posthuma
5 Reinier de Graaf Gasthuis, Department of Internal Medicine, Delft, The Netherlands
Josée Zijlstra
7 Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Department of Hematology, Amsterdam, The Netherlands
Martine Chamuleau
7 Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Department of Hematology, Amsterdam, The Netherlands
Pieternella Lugtenburg
8 Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, Rotterdam, The Netherlands
Marie José Kersten
7 Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Department of Hematology, Amsterdam, The Netherlands
Avinash Dinmohamed
1 Erasmus University Medical Centre, Department of Public Health, Rotterdam, The Netherlands